Treating heart failure with enhanced external counterpulsation (EECP): Design of the prospective evaluation of EECP in heart failure (PEECH) trial

Journal of Cardiac Failure

Volumn 11, Issue 3, 2005, Pages 240-245

  Feldman, Arthur M ^a   Silver, Marc A ^b   Francis, Gary S ^c   De Lame, Paul André ^d   Parmley, William W ^e  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b ADVOCATE CHRIST MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Anabase International   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical trial; Enhanced external counterpulsation; Heart failure

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUROHORMONE;

ARTICLE; CARDIOMYOPATHY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNTERPULSATION; DISEASE CLASSIFICATION; EXERCISE TOLERANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MEDICAL SOCIETY; MULTICENTER STUDY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STANDARD; SYMPTOM; TREADMILL; UNITED STATES;

EID: 16244419352     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2004.10.001     Document Type: Article

References (8)

1. American Heart Association Heart disease and stroke statistics - 2004 update 2003 American Heart Association Dallas (TX)
2. R.R. Arora, T.M. Chou, D. Jain, B. Fleishman, L. Crawford, and T. McKiernan The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes J Am Coll Cardiol 33 1999 1833 1840
3. O. Soran, E.D. Kennard, S.F. Kelsey, R. Holubkov, J. Strobeck, and A.M. Feldman Enhanced external counterpulsation as treatment for chronic angina in patients with left ventricular dysfunction: a report from the International EECP Patient Registry (IEPR) Congest Heart Fail 8 2002 297 302
4. O. Soran, B. Fleishman, T. Demarco, W. Grossman, V.M. Schneider, and K. Manzo Enhanced external counterpulsation in patients with heart failure: a multicenter feasibility study Congest Heart Fail 8 2002 204 208
5. Heart Failure Society of America (HFSA) HFSA practice guidelines: HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - pharmacological approaches J Card Fail 5 1999 357 362
6. J.E. Ware SF-36 health survey: manual and interpretation guide 1993 Nimrod Press Boston (MA)
7. T.S. Rector, and J.N. Cohn Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group Am Heart J 124 1992 1017 1025
8. M.R. Bristow, A.M. Feldman, L.A. Saxon, and for the COMPANION Steering Committee and COMPANION Clinical Investigators Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial J Card Fail 6 2000 276 285